Workup Peptides in the acidic cleaving solution were precipitated in pre-chilled diethyl ether (9:1 diethyl ether/cleavage mixture v/v) at 20 C for 30 min
Sulphonylureas (e.g., gliclazide, glimepiride): These medications stimulate insulin release and carry an inherent hypoglycaemia risk
Typical compounded tirzepatide eligibility (FormBlends criteria): BMI 25+ with documented weight-loss attempts, OR BMI 27+ regardless of prior attempts, OR Type 2 diabetes or prediabetes at any BMI The lower BMI threshold (25 vs 27) reflects provider discretion
The precipitated enzyme was removed by centrifugation, 200 l of the supernatant was transferred to a 96-well plate and the absorbance of the ferric-hydroxamate complex at 540 nm was measured by a Tecan M200 plate reader
DOI: 10.1056/NEJMoa2505669, Zhang, J., Wei, J., Lai, W., et al
Transmit claim online to RxBIN 018844